Patent details

EP3641820 Title: COMPOSITIONS COMPRISING AN ANTI-INFLAMMATORY DRUG AND A DICER ACTIVATOR FOR USE IN THE TREATMENT OF NEURONAL DISEASES

Basic Information

Publication number:
EP3641820
PCT Application Number:
IL2018050684
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187532569
PCT Publication Number:
WO2018235082
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS COMPRISING AN ANTI-INFLAMMATORY DRUG AND A DICER ACTIVATOR FOR USE IN THE TREATMENT OF NEURONAL DISEASES
French Title of Invention:
COMPOSITIONS COMPRENANT UN MÉDICAMENT ANTI-INFLAMMATOIRE ET UN ACTIVATEUR DICER DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT DE MALADIES NEURONALES
German Title of Invention:
ZUSAMMENSETZUNGEN MIT EINEM ENTZÜNDUNGSHEMMER UND EINEM DICER-AKTIVATOR ZUR VERWENDUNG BEI DER BEHANDLUNG VON NERVENERKRANKUNGEN
SPC Number:

Dates

Filing date:
20/06/2018
Grant date:
28/12/2022
EP Publication Date:
29/04/2020
PCT Publication Date:
27/12/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/12/2022
EP B1 Publication Date:
28/12/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/06/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/12/2022
 
 

Name:
Neurosense Therapeutics Ltd.
Address:
85 Medinat Hayehudim, 4676670 Herzeliya, Israel (IL)

Agent

Name:
Schulz Junghans Patentanwälte PartGmbB
From:
25/01/2023
Address:
Großbeerenstraße 71, 10963, Berlin, Germany (DE)
To:

Inventor

Name:
BEN-NOON, Alon
Address:
Israel (IL)

Priority

Priority Number:
201762522157 P
Priority Date:
20/06/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/415; A61K 31/47; A61K 31/496; A61K 45/06; A61P 25/00; A61P 25/16; A61P 25/14; A61P 25/28; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
202252
Publication date:
28/12/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
20/06/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
AZAMI GLOBAL INC GROUP (Former The International R
Filing date Document type Number of pages
25/01/2023 Power Of Attorney 1
25/01/2023 Outgoing Correspondence 1